Ledger.Open graph →
SEC Form D · Amendment · filed October 11, 2018

E-scape Bio, Inc

Offering
$63.0M
Sold
$63.0M
Exemption
Rule 506(b)
Industry
Biotechnology
Location
SOUTH SAN FRANCISCO, CA
Type
—

Rule 506(b): private placement to accredited investors, no public advertising.

People & firms on this filing (17)

Peter A. Thompson · South San Francisco, CADirectorAsish S. Xavier · South San Francisco, CADirectorJudith A. Li · South San Francisco, CADirectorPeter A. Moldt · South San Francisco, CADirectorRon Gershoni · Oakland, CADirectorR. S. Williams · Thousand Oaks, CADirectorPerry A. Karsen · South San Francisco, CADirectorMarkus A. Goebel · South San Francisco, CADirectorJulie A. Smith · South San Francisco, CAExec · DirectorDavid Allen · London, United KingdomDirectorR. S. Williams · Thousand Oaks, CADirectorPerry A. Karsen · South San Francisco, CADirectorAsish S. Xavier · South San Francisco, CADirectorJudith A. Li · South San Francisco, CADirectorMarkus A. Goebel · South San Francisco, CADirectorPeter A. Moldt · South San Francisco, CADirectorJulie A. Smith · South San Francisco, CAExec · Director

Public SEC Form D (Reg D) filing. · View issuer on SEC EDGAR ↗